[Prospective monitoring of a  university rheumatology outpatient clinic throughout the first wave of the COVID-19 pandemic : What lessons can be learned?]

CONCLUSION: The total lack of confirmed SARS-CoV‑2 infections in an otherwise strongly affected region could indicate that the infection risk for SARS-CoV‑2 is not substantially increased for patients with inflammatory rheumatic diseases. A continuation of most immunosuppressive medications therefore seems reasonable during the ongoing pandemic.
PMID: 33258019 [PubMed - as supplied by publisher]

Source: Zeitschrift fur Rheumatologie - November 30, 2020 Category: Rheumatology Authors: Braunisch MC, Bachmann Q, Hammitzsch A, Lorenz G, Geisler F, Schmaderer C, Heemann U, Moog P Tags: Z Rheumatol Source Type: research